ABSTRACT
Background: The large proportion of coronavirus disease 2019 (COVID-19) patients has been associated with a large number of neu-ropsychiatric manifestations. Despite the high prevalence of COVID-19, few studies have examined such manifestations, especially in children and adolescents. Objective(s): This study investigated neuropsychiatric manifestations in hospitalized children and adolescents admitted for COVID-19 infection in Iran. Method(s): This prospective observational study included admitted children and adolescents (4-18 years old) diagnosed with COVID-19 infection, pediatric neurologists, child and adolescent psychiatrists, and infectious disease specialists, and assessed 375 infected patients during August and December 2021. Result(s): Of the 375 patients, 176 (47%) were female, with a mean age of 9.0 +/- 3.39 years. Psychiatric and neurological manifestations were reported in 58 (15.5%) and 58 (15.5%) patients, respectively. The most prevalent psychiatric disorders were separation anxiety disorder (SAD) (5.1%), major depressive disorder (MDD) (3.5%), generalized anxiety disorder (GAD) (2.7%), insomnia (2.4%), and op-positional defiant disorder (ODD) (2.4%). Regarding neurological complications, seizures were the most prevalent (13.1%), followed by encephalitis (1.9%), transverse myelitis (0.3%), acute ischemic stroke (0.3%), and Guillain-Barre syndrome (0.3%). There was no significant relationship between the duration of COVID-19 infection (P = 0.54) and ICU admission (P = 0.44) with the emergence of psychiatric symptoms. Conclusion(s): The most prevalent neurologic and psychiatric complications among children and adolescents with COVID-19 infection were seizures and the symptoms of anxiety/mood disorders, respectively.Copyright © 2023, Author(s).
ABSTRACT
Hazards' trade-off benefits should be considered. COVID is usually not severe in children/vs. the fact of high transmission esp. adolescence with high social communications. MISC in children may be severe. The new COVID-19 variants spread more quickly and cause more severe diseases. Millions of doses of the COVID-19 vaccine have been given, and there have only been 1,000 cases of heart inflammation. CDC: Notes that for every million doses given, there have been 67 cases of heart inflammation in boys 12 to 17 (nine in girls of that age group), 56 in those aged 18 to 24 (six in girls), and 20 in males 25 to 29 (three in girls). That means the risk is relatively low. COVID-19 can affect the heart, too - not only as part of MIS-C, a multisystem inflammatory complication of COVID-19 seen in children but also just from the infection itself. COVID-19 can cause heart damage, including myocarditis. Our only way out of this pandemic is to get as many people vaccinated as possible, including young people. Vaccinated youth can safely go to school or camp, play sports, and be with their friends and families, all of which are important for their current and future health and well-being - and all of which were curtailed during the pandemic. The FDA reviewed a study of more than 2,259 U.S. children ages 12 through 15. Of this group, about half were given the Pfizer-BioNTech COVID-19 vaccine, and the other children were given an inactive (placebo) shot. The results suggest that the vaccine is 100% effective at preventing COVID-19. In this age group, kids now make up an increasingly large share of the cases. There were at least American Academy of pediatrics 243,000 cases of COVID-19 in children from Sept 2 to Sept 9 Sept 9 in the U.S. (roughly 29% of all cases in the country).
ABSTRACT
Due to our mistake in entering the affiliation and name of Mojgan Sarmadi in our article (Article ID: 110201, DOI: 10.5812/pedinfect.110201), we would like to apologize for any inconvenience made to our author and her affiliated organization, which is "National Institute of Dental and Craniofacial Research, Oral Immunity and Infection Unit, Oral and Pharyngeal Cancer Branch, National Institute of Health, Bethesda, MD 20892, US". We declare the correct affiliation of Mojgan Sarmadi is a private practice. © 2022, Author(s).
ABSTRACT
Introduction: Since the end of December 2019, most countries have been affected by the coronavirus disease 2019 (COVID-19) epidemic. The prevalence of COVID-19 in children has been reported much lower than adults. Most patients have mild symptoms, whereas some cases are asymptomatic. Information on the pediatric clinical manifestations is limited;therefore, reporting specific cases can improve the diagnosis process. Case Presentation: In this article, we reported a 12-year-old boy with chickenpox and COVID-19 at the same time. The patient initially had symptoms of chickenpox and then developed pneumonia. The PCR-test for COVID-19 was positive. The IgM test was positive, and IgG was negative. Chickenpox infection was confirmed by the serological test (positive IgM). The radiographic results showed reverse halo sign and vascular enlargement. Conclusion(s): These imaging findings are uncommon signs of COVID-19 in pediatrics. The patient was treated with hydroxychloro-quine and azithromycin and discharged a few days later with good condition. Copyright © 2020, Author(s).